Literature DB >> 19248134

Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis.

José Luis Fernández-Sueiro1, Alfredo Willisch, Sonia Pértega-Díaz, José Antonio Pinto Tasende, Carlos Fernández-Lopez, Fausto Galdo, Francisco Javier Blanco.   

Abstract

OBJECTIVE: To determine the clinical usefulness of spinal mobility measurements used for ankylosing spondylitis (AS) to assess spinal involvement in patients with psoriatic arthritis (PsA).
METHODS: We assessed 100 patients with PsA and 103 patients with AS. Patients were classified as having axial PsA if they had grade 2 or higher unilateral sacroiliitis in the presence of spinal symptoms. All PsA patients, without taking the degree of joint involvement into consideration, were evaluated using several measurements for AS. Spinal measurements were compared with axial and peripheral forms of PsA, and the ability of the techniques to discriminate between the 2 forms of PsA was analyzed using the Mann-Whitney U test and the area under the receiver operating characteristic (ROC) curve. A logistic regression model was used to determine the best measurements for evaluating axial PsA. Finally, the results of measurements for axial PsA were compared with those for AS.
RESULTS: Of the 100 PsA patients, 46 met the classification criteria for axial PsA, which presented more severe spinal measurement assessments compared with peripheral PsA. Modified Schober test, lumbar side flexion, chest expansion, and cervical rotation measurements performed best under the ROC curve. Modified Schober test, lumbar side flexion, and cervical rotation were the more suitable measurements for assessing axial PsA. There were only minor differences between axial PsA and AS.
CONCLUSION: The spinal measurements used to evaluate AS performed well to assess spinal involvement in PsA. These measurements, notably the modified Schober test, lumbar side flexion, and cervical rotation, should be used in daily clinical practice to assess PsA patients with spinal involvement.

Entities:  

Mesh:

Year:  2009        PMID: 19248134     DOI: 10.1002/art.24280

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  Assessment and treatment of psoriatic spondylitis.

Authors:  Peter Nash
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

2.  A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis.

Authors:  Anna Rita Giardina; Angelo Ferrante; Francesco Ciccia; Rosalia Impastato; Maria Concetta Miceli; Alfonso Principato; Giovanni Triolo
Journal:  Rheumatol Int       Date:  2009-10-23       Impact factor: 2.631

3.  Evaluation of spinal mobility measurements in predicting axial psoriatic arthritis.

Authors:  Ying-ying Leung; Kwok Wah Ho; Lai Shan Tam; Tracy Y Zhu; Lai W Kwok; Tena K Li; Emily W Kun; Edmund K Li
Journal:  Clin Rheumatol       Date:  2011-03-03       Impact factor: 2.980

Review 4.  Clinical assessment and outcome research in spondyloarthritis.

Authors:  Robert B M Landewé; Astrid van Tubergen
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

Review 5.  Tools for monitoring spondyloarthritis in clinical practice.

Authors:  Astrid M van Tubergen; Robert B M Landewé
Journal:  Nat Rev Rheumatol       Date:  2009-10-06       Impact factor: 20.543

6.  HLA-B27 frequency in a group of patients with psoriatic arthritis.

Authors:  Danilo Garcia Ruiz; Mário Newton Leitão de Azevedo; Omar Lupi
Journal:  An Bras Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.896

7.  Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.

Authors:  Fausto Salaffi; Alessandro Ciapetti; Marina Carotti; Stefania Gasparini; Gustavo Citera; Marwin Gutierrez
Journal:  Health Qual Life Outcomes       Date:  2014-08-22       Impact factor: 3.186

8.  Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort.

Authors:  Margarita Landi; Hernán Maldonado-Ficco; Rodolfo Perez-Alamino; José A Maldonado-Cocco; Gustavo Citera; Pablo Arturi; Percival D Sampaio-Barros; Diana E Flores Alvarado; Rubén Burgos-Vargas; Elena Santos; Daniel Palleiro; Miguel A Gutiérrez; Elsa Vieyra-Sousa; Fernando Pimentel-Santos; Sergio O Paira; Alberto Berman; Claudia Vera Barrezueta; Janitzia Vazquez-Mellado; Eduardo Collantes-Estevez
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 9.  Patient involvement in outcome measures for psoriatic arthritis.

Authors:  William Tillett; Ade Adebajo; Mel Brooke; Willemina Campbell; Laura C Coates; Oliver FitzGerald; Laure Gossec; Philip Helliwell; Sarah Hewlett; Jana James; Patricia Minnock; Aisling Reast; Dennis O'Sullivan; Maarten de Wit; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2014-05       Impact factor: 4.592

10.  Measuring disease activity in psoriatic arthritis.

Authors:  Priscilla C H Wong; Ying-Ying Leung; Edmund K Li; Lai-Shan Tam
Journal:  Int J Rheumatol       Date:  2012-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.